Email UpdatesSubstance Abuse Confidentiality Regulations FAQs
Webpage with frequently asked questions (FAQs) related to laws and regulations about SBIRT and substance use services
Regulations & Recordkeeping
Facilitate compliance with relevant laws, rules, and regulations of substance use disorder treatment and MAT services, including those from the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Administration.
How HIPAA Allows Doctors To Respond to the Opioid Crisis
Provides information about when healthcare professionals are legally allowed to disclose some health information related to OUD without a patient's permission.
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40.
Provides guidance on the use of buprenorphine among a number of topics, including physiology and pharmacology of opioids, opioid addiction, and buprenorphine treatment; screening and assessment of OUDs; protocols for buprenorphine treatment; management of special populations; and policies and procedures related to DATA 2000.
Understanding the Final Rule for a Patient Limit of 275
Describes what physicians need to know about the patient limit of 275, such as eligibility and credentials.
Disclosure of Substance Use Disorder Patient Records: How Do I Exchange Part 2 Data?
Describes how 42 CFR Part 2 applies to the electronic exchange of healthcare records within certain programs.
Disclosure of Substance Use Disorder Patient Records: Does Part 2 Apply to Me?
Explains how healthcare providers can determine if 42 CFR Part 2 applies to them.
Buprenorphine Prescription Log
Provides a log for buprenorphine prescriptions that can be kept by physicians or buprenorphine-treated patients.
Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorders
Reviews three FDA-approved medications for OUD treatment (methadone, naltrexone, and buprenorphine) and the other strategies and services needed to support people in recovery.
Accountability Record for Stock Buprenorphine Supplies
Provides a template to track inventory of stock buprenorphine supplies, including patient, quantity dispensed, and manufacturer and lot number.
Overcoming Data-Sharing Challenges in the Opioid Epidemic: Integrating Substance Use Disorder Treatment in Primary Care
Summarizes the requirements of confidentiality rules set forth under the Code of Federal Regulations (CFR) and suggests steps primary care practices can take to maintain compliance.